American Oncology Network Launches New Cancer Foundation

/in /by

American Oncology Cares Foundation and fund provide non-medical financial assistance to adult cancer patients.

FORT MYERS, Fla., November 2, 2023 – American Oncology Network (AON) (Nasdaq: AONC) announced today the launch of its cancer foundation, the American Oncology Cares Foundation. The Foundation will raise funds to provide essential non-medical financial assistance for adult cancer patients.

Cancer is one of the most expensive diseases to treat. According to a National Cancer Institute study, over 70% of cancer patient study participants reported some sort of financial hardship within the first 12 months of starting treatment. These hardships included at least one of the following situations: debt accumulation, money borrowing from family and/or friends, house selling or refinancing, and a decline in personal income.

“As cancer diagnoses increase, financial funds that are available to support patients decrease,” said Todd Schonherz, AON’s chief executive officer. “That is why we have created the American Oncology Cares Foundation — to provide another source of financial assistance to patients who are in need. Our goal is to alleviate some of the financial burden associated with essential living expenses so that patients can refocus on what really matters — their health journey.”

American Oncology Cares Foundation is utilizing non-profit America’s Charities to administer and manage the fund as well as to review patient applications and distribute patient grants. The fund is designed to be used for housing expenses; utility bills such as gas, water and electric; and transportation and food costs associated with travel to and from cancer treatments.

Patients must meet the criteria to qualify for financial assistance: 

  • The patient must be receiving active cancer treatment.
  • The patient must be at least 18 years old. 
  • The patient’s household income must be at or below 200% of the U.S. Federal Poverty Guidelines.
  • Reside in a state where a participating AON practice is located.

Qualified patients can receive a grant of up to $750 per calendar year. Patients can complete the online application at charities.org/AONCares.

“Financial hardships related to cancer treatment take a strenuous toll on patients’ mental and physical well-being, hindering their overall healthcare journey,” said Carlos E. Arce-Lara, MD, medical oncologist and hematologist at Cancer & Blood Specialists of Arizona. “On behalf of the clinic, we are proud supporters of and contributors to the American Oncology Cares Foundation and fund. I look forward to seeing this fund grow and provide financial relief to many deserving patients.”

“While the fund currently operates solely in Arizona and Ohio, we are in the process of expanding this initiative with the hope that patients in all states in which AON operates will one day be able to benefit from the fund,” said Shelly Glenn, AON’s chief growth and relationship officer. “American Oncology Cares Foundation is a means where we can make a larger difference beyond providing high-quality cancer care in our clinics. Our patients are our core focus in all that we do, and I am excited to be a part of the Foundation’s launch.”

To begin an application, visit charities.org/AONCares. To donate to the fund, visit aoncology.com/AONCares. 

For more information about AON, visit www.aoncology.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents more than 220 providers practicing across 20 states. The executive management team of AON encompasses more than four decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at aoncology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

American Oncology Network Leaders Slated To Speak at Association for Value-Based Cancer Care 2023 Summit

/in /by

Members of AON’s leadership team will speak and moderate several panel sessions at the Summit.

FORT MYERS, Fla., October 18, 2023 – American Oncology Network (AON) (Nasdaq: AONC) is pleased to announce that Stephen “Fred” Divers, MD, chief medical officer; James Gilmore, PharmD, chief pharmacy and clinical services officer; and Alti Rahman, MHA, MBA, CSSBB, chief strategy and innovation officer; and Susan Sabo-Wagner, MSN, RN, OCN, vice president of clinical innovation, have been invited to speak at the Association for Value-Based Cancer Care (AVBCC) 2023 Summit. The in-person event is scheduled for October 18 through October 20 in New York.

Members of AON’s leadership team that will speak and moderate several panel sessions at the Summit.

Divers, Gilmore, Rahman and Sabo-Wagner, who are members of AON’s leadership team, serve as Summit faculty and will be speaking and moderating specific sessions:

  • Divers will participate on the panel for the following session: “Clinician Leadership Role in Transforming Cancer Care.”
  • Gilmore will participate on the panel for the following session: “Value-Based Agreements in Oncology: What Cancer Care Practices are Doing in the Marketplace Today.”
  • Rahman will participate on the panel for the following sessions: “Challenges in Transitioning to Value-Based Care,” “Transforming the Oncology Practice Clinically and Financially,” “The Essential to Achieving Success in Value-Based Care: Medically Integrated Pharmacies & Dispensaries,” and “How Do I Handle Bundle Payments.” Rahman will also moderate the following panel sessions: “Beyond EOM: How does Health Equity Fit in Multi-Stakeholder Value-Based Care Partnership” and “Artificial Intelligence and the Impact on Care Delivery Outcomes.” 
  • Sabo-Wagner will participate on the panel for the following session: “Beyond EOM: How does Health Equity Fit in Multi-Stakeholder Value-Based Care Partnership.”

“Cancer is constantly evolving, and it requires us, as healthcare leaders and patient advocates, to follow suit and continuously elevate our learning so that we can improve patient outcomes,” said Divers, who also serves as a board member of Community Oncology Alliance. “The cancer fight is everyone’s responsibility and so much can be learned by looking to our partners throughout the industry and taking note of best practices. I am excited and honored to be a part of the panel discussion and to see my fellow AON leaders speaking in sessions so that we can explore best cancer practices in today’s environment together.”

“Value-based care is a main force that can close the cancer care gap and create healthcare equity,” said Rahman, who also serves as co-chair of AVBCC and a board member of Community Oncology Alliance. “I am passionate about these topics and sharing my knowledge in hopes to educate and inspire others to learn more about value-based care and more importantly, look for ways to increase access to care so that everyone can receive the right care at the right time.”

According to the AVBCC website, the Summit brings together over 300 experts across the oncology landscape including practitioners, pharmacists, payers, policymakers and other key stakeholders. Filled with various educational sessions, attendees will gain insightful and relevant information that can be implemented in clinics and institutions.

“We are honored to have representatives from AON speaking at this prestigious event,” said Todd Schonherz, AON’s chief executive officer. “To us as an organization, it is important that we consistently work toward being at the forefront of cancer care. We do this by sharing our expertise in the field with others so that cancer care is elevated and progresses alongside the advancements in medicine and technology.”

In addition to speaking at the Summit, Rahman and Sabo-Wagner have been invited to speak at the Community Oncology Alliance (COA) Payer Exchange Summit on Oncology Payment Reform event in late October and the Patient-Centered Oncology Care® conference in early November.

For more information about AON, visit www.aoncology.com. To learn more about the AVBCC’s Summit, visit www.valuebasedcancer.com/avbcc/2023-summit.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents 109 physicians and 96 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than four decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at aoncology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

Messino Cancer Centers and American Oncology Network Celebrate Appointment of Local Physician to the NC Advisory Committee on Cancer Coordination and Control

/in /by

Local medical oncologist Rachel E. Raab, MD, will serve on the committee for the next four years.

ASHEVILLE, N.C., October 12, 2023 –  Messino Cancer Centers and American Oncology Network (AON) (Nasdaq:AONC) are pleased to announce that Rachel E. Raab, MD, has been appointed by Governor Roy Cooper to the North Carolina Advisory Committee on Cancer Coordination and Control, effective September 8.

Dr. Raab is a Board-certified medical oncologist at community oncology practice Messino Cancer Centers. She has experience treating patients with various cancer types but has a special interest and expertise in breast and gynecologic cancers.

She has been a practicing provider in the Asheville area since June 2015. She is an active member of the American Society of Clinical Oncology and the North Carolina Medical Society. Dr. Raab received her medical degree from East Carolina University and then completed a hematology and oncology residency and fellowship at Albert Einstein College of Medicine, Montefiore Medical Center.

“I am honored and grateful to be appointed to this committee,” said Raab. “The committee is dedicated to improving cancer care in the state as well as access to high-quality care and services to improve the mortality rate. I have dedicated my career to patient care, ensuring my patients receive the care they need at the right time. I look forward to collaborating with other like-minded healthcare leaders who sit on the committee and to collectively advance cancer care in North Carolina.”

According to the North Carolina Advisory Committee on Care Coordination and Control website, their mission is to “facilitate the reduction of cancer incidence and mortality for all North Carolinians, enhance statewide access to quality treatment and support services, and maximize the quality of life for all North Carolina cancer survivors, patients, and their loved ones through educating and advising government officials, policy makers, public and private organizations, and the public.” Appointed members serve a four-year term, and the committee meets twice a year.

“We are excited to hear of Dr. Raab’s appointment to this prestigious and important committee,” said AON Chief Medical Officer Stephen “Fred” Divers, MD. “Improving cancer care as well as access to these critical treatments requires a collaborative approach of thoughtful healthcare leaders. This committee is designed to do just that, and we are excited that a physician in our network has been recognized to serve on it. Dr. Raab’s expertise and experience will provide value to the committee and community, and I look forward to her contributions over the next four years.”

For more information about AON, visit www.aoncology.com. For more information about Messino Cancer Centers, visit messinocancercenters.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents 109 physicians and 96 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than four decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at aoncology.com.

About Messino Cancer Centers
Messino Cancer Centers (MCC) provides treatment for adult patients diagnosed with all types of cancer and blood disorders. Messino Cancer Centers is grounded in the Western North Carolina region and devoted to providing personalized care of the highest quality to patients in community settings, close to where they live and work and where their loved ones are close by. We are proud of our 30-year history of providing the highest quality cancer treatment that is based on research and focused on the whole person. 

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network, LLC
Caroline.Hewitt@AONcology.com

American Oncology Network to Host Annual Clinical Summit Conference in Las Vegas

/in /by

The conference brings together healthcare and community oncology leaders for clinical education programs
and industry updates.

FORT MYERS, Fla., October 11, 2023 – American Oncology Network (AON) (Nasdaq: AONC) is pleased to announce its annual Clinical Summit conference, which is scheduled for October 12 through October 15 at the Bellagio Hotel in Las Vegas.

The conference brings together the network’s healthcare and oncology leaders and physicians from across the nation for a multi-day event. Attendees will discuss and learn about the latest advancements in oncology that will elevate patient care, all under the central theme of ‘Collaborate, Innovate and Celebrate.’

In addition to educational sessions and informative AON and industry update breakouts, this year’s conference features guest speaker Diely Pichardo, MD, a retired hematologist-oncologist, who will deliver the interactive session on well-being and career longevity. Attendees will also earn continuing medical education credits with Dr. Neil Love’s Research to Practice CME program and have access to a clinical trial and research session provided by AON clinical research leadership.

“The Clinical Summit is an exciting event that provides a platform for learning about the latest trends, sharing knowledge and building connections with others in community oncology so that cancer care can be improved,” said Todd Schonherz, AON’s chief executive officer. “The conference fosters innovation and collaboration within our community oncology industry, and we look forward to welcoming our physicians and leaders to this year’s event.”

AON is one of the nation’s fastest-growing networks focused on ensuring the viability of community oncology. Since its inception in 2018, the company has expanded to include over 200 healthcare providers in more than 75 clinics and has a current presence in 19 states.

“This year’s theme captures the AON journey perfectly,” said Stephen “Fred” Divers, MD AON’s chief medical officer and medical oncologist at Genesis Cancer and Blood Institute, one of AON’s first partner practices to join the organization. “AON celebrated its fifth anniversary in September, and as we look back on the past five years, we reflect on the tremendous impact that collaboration and innovation have had on AON’s success. The theme ‘Collaborate, Innovate and Celebrate’ is an ode to AON and the teams who have dedicated themselves to bringing AON to where it is today.”

For more information about AON, visit www.aoncology.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents 109 physicians and 96 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than four decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at aoncology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

American Oncology Network CEO To Speak at 2023 Clinical Pathways Congress + Cancer Care Business Exchange

/in /by

The annual Congress is the meeting place for stakeholders to reimagine how the industry delivers and pays for cancer care with a focus on improving outcomes for patients.

FORT MYERS, Fla., October 5, 2023 – American Oncology Network (AON) (Nasdaq: AONC) is honored to be represented by its CEO, Todd Schonherz, at HMP Global’s Clinical Pathways Congress + Cancer Care Business Exchange on October 6 through October 8 in Boston. Schonherz, who also serves as a member of the Congress leadership and faculty, has been invited to speak on a panel titled “Healthcare Industry Consolidation: The Impact on Cancer Care and Strategic Partnerships.”

The 2023 Congress is the official meeting of the Journal of Clinical Pathways, a peer-reviewed journal that works to advance the discussion of clinical pathways to provide high-quality, cost-effective care. The 2023 Congress is a three-day accredited educational program (CME) with business-changing insights, practical strategies, and key exchanges with innovators and provides attendees with actionable solutions to complexities in cancer care delivery and payment.

AON is one of the fastest-growing community oncology networks in the United States and is committed to ensuring equitable cancer care is a reality for all patients. “Cancer care needs to change, and patients deserve better and improved access to high-quality care,” said Schonherz. “We must focus on improving health outcomes and care access for patients by advancing the conversation among stakeholders who have influence and impact on the evolving business models and delivery of cancer care.”

Attendees can see Schonherz speak at the following time:

  • Friday, October 6, 4:00-5:00 PM EST, Panel Discussion: Healthcare Industry Consolidation: The Impact on Cancer Care and Strategic Partnerships

This year’s Congress creates an interactive environment for cancer care stakeholders to explore and share practical approaches to issues that are relevant to them today such as:

  • Ensuring enterprise viability in an environment of healthcare industry consolidation and vertical integration. 
  • Combatting resource constraints especially relating to infusion services. 
  • Overcoming manpower shortages in an environment where providers are retiring at an unprecedented rate. 
  • Leveraging data to inform clinical and business decision-making.

Organized by HMP Global, the leading omnichannel healthcare events and education company, CPC/CBEx is a high-level, multi-stakeholder forum focusing on actionable business solutions within the complex environment of cancer care delivery and payment. The Congress provides a comprehensive learning and networking opportunity for all stakeholders in the cancer care continuum.

For more information about the event or to register for the panel discussion, visit clinicalpathwayscongress.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents 109 physicians and 96 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than four decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at aoncology.com.

About HMP Global
HMP Global is the force behind Healthcare Made Practical — and is an omnichannel leader in healthcare content, events, and education, with a mission to improve patient care. The company produces accredited medical education events — in person and online via its proprietary VRTX virtual platform — and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. Its brands include the HMP Global Learning Network, healthcare’s most comprehensive source for news and information; mental health education through the Neuroscience Education Institute and Psych Congress national, regional and global events; HMP Market Access Insights, the pharmaceutical industry’s gold standard provider for cancer drug market insights; the Leipzig Interventional Course (LINC), the leading, global gathering for interdisciplinary cardiovascular specialists; EMS World Expo, North America’s largest EMT and paramedic event; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. For more information, visit hmpglobal.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

American Oncology Network and Digital Transformation Opportunities Corp. Announce Completion of Business Combination

/in /by

AON to Ring Nasdaq’s Closing Bell on September 21, 2023, to Commemorate First Day of Trading

FORT MYERS, Fla. and LOS ANGELES, September 20, 2023 – American Oncology Network, LLC (“AON” or the “Company”), a rapidly growing network of community-based oncology practices, and Digital Transformation Opportunities Corp. (Nasdaq: DTOC) (“DTOC”), a special purpose acquisition company focused on the healthcare industry, announced today the completion of their previously announced business combination (the “Business Combination”).

The combined company has been renamed American Oncology Network, Inc., and its common stock is expected to commence trading on the Nasdaq Stock Market LLC (“Nasdaq”) under the new ticker symbol “AONC” on September 21, 2023. The Business Combination was approved at a special meeting of DTOC’s stockholders on September 19, 2023.

In just five years since its inception in 2018, AON has grown to include over 1,500 employees and over 200 providers in more than 75 clinics serving over 450,000 patients nationwide. AON practices have access to fully integrated ancillary services such as a specialty pharmacy, lab and pathology, radiation therapy, and imaging. These services promote clinical coordination and seamless communication throughout all stages of the care process. AON practices deliver high-quality patient care by sharing resources and expertise across the network, providing access to leading clinical trials, staying at the forefront of clinical innovation, and advocating for their patients and the profession of community oncology.

The DTOC partnership and recent strategic investment from AEA Growth, a leading global investment firm, will help further AON’s goals of supporting community oncology practices and improving the patient experience by unlocking further growth through continuing to add new providers to the AON network, scaling ancillary services, introducing new service offerings, and expanding AON’s existing services to address the broader oncology market.

“Today is an important milestone for AON and celebrates our team’s hard work and dedication, which have been the keys to our growth and success,” said Todd Schonherz, Chief Executive Officer of AON. “AON is committed more than ever to expanding our reach and advancing cancer care in communities across the nation where too often patients experience accessibility barriers.”

“We are proud of our successful partnership with AON and look forward to seeing the company’s profound impact enable advanced treatment options, clinical research, and comprehensive care options nationwide,” said Kevin Nazemi, Chief Executive Officer of DTOC.

The combined company will continue to be led by AON’s Chief Executive Officer, Todd Schonherz; Chief Financial Officer, David Gould; and Chief Medical Officer, Dr. Stephen “Fred” Divers.

Paul Hastings LLP served as legal advisor to DTOC. Woolery & Co. PLLC and Dentons US LLP served as legal advisors to AON.

###

About American Oncology Network
The American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents 109 physicians and 86 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than four decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients. Learn more at www.aoncology.com.

About DTOC
Digital Transformation Opportunities Corp. is a blank check company, led by Kevin Nazemi, Co-Founder and former Co-CEO of Oscar Health, formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. DTOC’s Board of Directors includes Kevin Nazemi, Brad Fluegel (former Chief Strategy Officer of Walgreens and Anthem), Jim Moffatt (former Vice Chairman and Global CEO of Deloitte Consulting), and Heather Zynczak (former Chief Marketing Officer of Pluralsight and Domo). DTOC is focused on businesses operating in the healthcare industry. To learn more about Digital Transformation Opportunities Corp., visit www.dtocorp.com.

About AEA Growth
AEA Growth provides technology-enabled, healthcare and software companies with flexible capital and operational resources to accelerate growth. AEA Growth targets investments in category-leading, capital-efficient businesses with strong customer advocacy.

AEA Growth is part of AEA Investors LP. AEA Investors was founded in 1968 by the Rockefeller, Mellon and Harriman family interests and S.G. Warburg & Co. as a private investment vehicle for a select group of industrial family offices with substantial assets. AEA has an extraordinary global network built over many years which includes leading industrial families, business executives and leaders; many of whom invest with AEA as active individual investors and/or join its portfolio company boards or act in other advisory roles. Today, AEA’s approximately 120 investment professionals operate globally with offices in New York, Stamford, San Francisco, London, Munich and Shanghai. The firm manages funds that have approximately $19 billion of invested and committed capital including the leveraged buyouts of middle market companies and small business companies, growth capital and private investments.

For more information, please contact:

For AON:
David Gould, Chief Financial Officer
David.Gould@aoncology.com

For DTOC:
Kyle Francis, Chief Financial Officer
kyle@dtocorp.com

Forward-Looking Statements

Certain statements in this press release are forward-looking statements. Forward-looking statements generally relate to future events including future financial or operating performance of American Oncology Network, Inc. (“New AON”). Forward-looking statements generally relate to future events or New AON’s future financial or operating performance. For example, projections of future revenue and other metrics are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential” or “continue”, or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements.

These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by New AON and its management, are inherently uncertain and are inherently subject to risks, variability and contingencies, many of which are beyond New AON’s control. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain key relationships and retain its management and key employees; (2) costs related to the Business Combination; (3) changes in applicable laws or regulations; (4) the possibility that New AON may be adversely affected by other economic, business, and/or competitive factors; (5) New AON’s estimates of expenses and profitability; and (6) other risks and uncertainties set forth in the section entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in New AON’s final prospectus relating to the Business Combination dated July 18, 2023 filed with the SEC, and in subsequent filings with the SEC. New AON cautions that the foregoing list of factors is not exclusive or exhaustive and investors should not place undue reliance upon any forward-looking statements, including projections, which speak only as of the date made. If any of these risks materialize or New AON’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that New AON does not presently know or that New AON currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect New AON’s expectations, plans or forecasts of future events and views as of the date of this communication. New AON anticipates that subsequent events and developments will cause New AON’s assessments to change. However, while New AON may elect to update these forward-looking statements at some point in the future, New AON specifically disclaims any obligation to do so, unless required by applicable law. These forward-looking statements should not be relied upon as representing New AON’s assessments as of any date subsequent to the date of this communication. New AON does not give any assurance that New AON will achieve its expectations. Accordingly, undue reliance should not be placed upon the forward-looking statements.

American Oncology Network and Summit Cancer Centers Expand Physician Team to Include Dr. Deepthi Kodali

/in /by

Dr. Kodali is accepting patients at the Summit Cancer Centers’ Spokane Valley clinic location.

SPOKANE, Wash., September 8, 2023 – Summit Cancer Centers, in partnership with American Oncology Network (AON), is pleased to welcome medical oncologist and hematologist Deepthi Kodali, MD, to the community. She is accepting patients at the clinic’s Spokane Valley location.

“On behalf of the care team at Summit Cancer Centers, we are excited to announce that Dr. Kodali has joined us,” said Arvind Chaudhry, MD, Ph.D., medical oncologist at Summit Cancer Centers. “Dr. Kodali’s dedication and passion will enhance our commitment to patient-centered care and medical excellence.”

Dr. Kodali is Board certified in internal medicine. She received her medical degree from Kasturba Medical College in Manipal, India, and completed an internal medicine residency at the University of Connecticut, and then an oncology-hematology fellowship at Winship Cancer Institute at Emory University in Atlanta, Georgia. She has a special interest in women’s health and breast cancer although she has experience treating various cancer types.

“I am eager to get started at Summit Cancer Centers and join the team of expert physicians,” said Kodali. “My approach to patient care is to first deliver compassionate, evidence-based and patient-centered care that is unique to each of my patients. I believe that fostering a strong doctor-patient relationship is fundamental to successful health outcomes. I am eager to build those connections within this supportive practice.”

“Dr. Kodali’s experience is a great addition to the clinic’s team,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “I would like to extend a warm welcome to Dr. Kodali and look forward to the positive impact her presence will have on the health and well-being of their patients.”

For more information about Summit Cancer Centers, visit www.summitcancercenters.com/. For more information about AON, visit www.aoncology.com/.

###

About Summit Cancer Centers
Summit Cancer Centers is a community-based medical and surgical oncology practice providing care for patients diagnosed with all types of cancer and blood disorders. We are experienced physicians, nurse practitioners, nurses and clinical support staff providing compassionate, patient-centered care in Washington and Idaho. Services include diagnostic imaging, nutritional counseling, cancer treatments with the most advanced therapies and technologies and clinical trials to onsite oral chemotherapy and lab services. Learn more at www.summitcancercenters.com/.

About American Oncology Network
The American Oncology Network (AON), an Inc. 5000-recognized company, is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 109 physicians and 86 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at www.aoncology.com/.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

American Oncology Network Celebrates Momentous Five-Year Anniversary of Closing the Cancer Care Gap

/in /by

Since its founding, AON has expanded into 19 states and counting.

FORT MYERS, Fla., September 5, 2023 – American Oncology Network (AON), one of the fastest-growing community oncology networks in the United States, proudly celebrated its fifth anniversary, commemorating a half-decade of excellence in advancing community oncology and driving value-based care initiatives to close the cancer care gap.

“Since AON’s founding in 2018, the organization has had an unwavering commitment to ensuring the viability of community oncology, supporting diversity in and accessibility of clinical trials at a local level and delivering high-quality compassionate cancer care and services,” said Todd Schonherz, AON’s chief executive officer. “I am immensely grateful and proud of the accomplishments of the AON teams and more importantly, the positive impact we have had in the lives of cancer patients. While we celebrate our five years of operation, we also celebrate and acknowledge the incredible journeys of resilience and hope undertaken by our patients whom we are honored to serve.”

AON is an alliance of physicians and veteran healthcare leaders dedicated to ensuring the long-term success of community-based oncology. AON has grown to include over 1,500 employees, close to over 200 providers in more than 75 clinics and operates in 19 states. The organization has cultivated partnerships with key leaders in healthcare and oncology services such as RXLightning and Thyme Care, which have assisted in the network’s expansive reach to over 450,000 unique patients nationwide.

“Our unique approach and physician-led model has allowed us to grow quickly over the last few years and at an impressive speed,” said Stephen “Fred” Divers, MD AON’s chief medical officer and medical oncologist at Genesis Cancer and Blood Institute in Hot Springs, Arkansas, one of AON’s first partner practices to join the organization alongside Hematology Oncology Clinic in Baton Rouge, Louisiana. “We have continued to advocate for our patients, pushing the boundaries of cancer treatments and research to ensure we are delivering the most advanced therapies available. The network’s dedicated team of experienced oncologists and medical staff as well as the internal teams at AON work tirelessly to make a meaningful difference. Congratulations to AON on five successful years.”

Through access to centralized services such as revenue cycle management, drug purchasing, payer contracting and IT, as well as enhanced services such as pathology and oral-oncolytic pharmacy, AON practices have realized significant results in increased productivity and improved operations.

Since its inception, AON achieved the following outcomes:

  • Over 390 patients enrolled in more than 100 clinical trials.
  • 63,000 PET/CT scans performed.
  • Close to 6,000 bone marrows performed.
  • 12.8 million clinical lab tests processed. 
  • Over 100,000 prescriptions filled. 
  • $185 million in medication and co-pay assistance.

“AON’s accomplishments are, without a doubt, inspiring and exciting for the community oncology profession,” said Shalin R. Shah, DO, AON’s Board of Managers Chairman. “Whereas there is much work still to be done in community oncology and in closing the cancer care gap, AON is an organization that is breaking the barriers to care, improving patient care and outcomes for many patients. Congratulations to AON for their accomplishments, and cheers to another five successful years.”

“This anniversary serves as an opportunity to reflect on our accomplishments as well as recommit to continuous growth, innovation and compassionate care,” said Schonherz. “As AON embarks onto this next chapter, we do so with the determination to remain at the forefront of community oncology and steadfast in our dedication to improving outcomes for cancer patients across the nation.”

For more information about AON, visit www.aoncology.com.

###

About American Oncology Network
The American Oncology Network (AON), an Inc. 5000-recognized company, is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents 109 physicians and 86 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at www.aoncology.com/.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

American Oncology Network and Cancer & Blood Specialists of NOVA Welcome New Physician

/in /by

Dr. Fiona Mienko joins the community oncology clinic and is accepting patients.

WOODBRIDGE, Va., September 5, 2023 – Cancer & Blood Specialists of NOVA, a partner practice of American Oncology Network, LLC (AON), is pleased to welcome Board-certified medical oncologist and hematologist Fiona Mienko, MD, to the clinic.

Dr. Mienko earned her medical degree from the University College Dublin in Dublin, Ireland. She completed an internal medicine residency at Mount Sinai Morningside and Mount Sinai West in New York and then a medical oncology and hematology fellowship at Montefiore Medical Center at the Albert Einstein College of Medicine in New York.

“As a physician, my commitment is to provide compassionate and personalized care to each of my patients,” said Mienko. “Joining Cancer & Blood Specialists of NOVA enables me to fulfill that mission wholeheartedly. I am eager to work alongside Dr. Chan and the rest of the care team at the clinic.”

Dr. Mienko’s training is vast as she has experience evaluating, diagnosing and treating patients with non-malignant and malignant hematological conditions and solid tumor malignancies. She is currently an active member of the American Society of Clinical Oncology and the American Society of Hematology.

“We are delighted to be bringing a new physician to the clinic,” said Farn Chan, MD, lead medical oncologist and hematologist at Cancer & Blood Specialists of NOVA. “Dr. Mienko’s experience will help us elevate the care we provide, and by her joining us, we are able to continue being an accessible oncology resource for our community.”

“Congratulations to Cancer & Blood Specialists of NOVA on expanding the provider team,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Dr. Mienko’s exceptional skills and dedication to delivering patient-first care will strengthen the clinic’s ability to deliver high-quality services to their community, further solidifying their unwavering commitment to their patients.”

Cancer & Blood Specialists of NOVA is a partner practice of AON and joined the network in May of 2020. Through the partnership, the clinic and its care team have access to additional clinic and patient services and resources that are essential to effective community oncology care.

For more information about AON, visit www.aoncology.com/. For more information about Cancer & Blood Specialists of NOVA, visit cancerandbloodspecialistsofnova.com/.

###

About American Oncology Network
The American Oncology Network (AON), an Inc. 5000-recognized company, is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents 109 physicians and 86 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at www.aoncology.com/.

About Cancer & Blood Specialists of NOVA
Cancer and Blood Specialists of NOVA has been a leading cancer treatment center for patients in the Northern Virginia Metropolitan area since 1987. State-of-the-art, patient-centered care is the focus of our treatment regimen. Our counseling incorporates genomic evaluations for targeted therapy in order to provide all patients with the personalized care they need. We provide the most advanced treatment options including chemotherapy, immunotherapy, iron infusions, bone marrow biopsies, and more. Our doctors refer to a variety of resources, allowing us to remain innovative in our treatment and up to date in the constantly changing world of oncology. A community-based practice, we offer a full range of exceptional cancer services, providing the highest quality treatment based on research and focused on the whole person. Learn more at cancerandbloodspecialistsofnova.com/. 

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

Triple Crown Urology Opens in Hot Springs, Arkansas, and Joins American Oncology Network

/in /by

Drs. Seth Hollenbach, Nathan Littlejohn and Renee Warford commit to continue delivering high-quality, comprehensive, patient-first care to the community.

HOT SPRINGS, Ark., September 1, 2023 – American Oncology Network (AON) is pleased to announce the opening of its first urology practice, Triple Crown Urology. Urologists Seth Hollenbach, MD; Nathan Littlejohn, MD; and Renee Warford, MD, joined AON’s vast network of healthcare practices.

Triple Crown Urology serves southwest Arkansas with clinics in Hot Springs, Hot Springs Village, Camden, Mena, Benton and Arkadelphia. The practice specializes in treating diseases and complications of the male and female urinary system as well as both benign and oncologic urologic issues. The providers use the latest advanced technology and have expertise in minimally invasive surgery, including robotic surgery, endoscopy, laparoscopy, Aquablation therapy and more. By joining AON as a partner practice, Triple Crown Urology will not only be able to continue providing urology care and services but also have access to additional resources that elevate patient care.

These additional services include a referral physician portal that allows for shared patient medical charts and seamless physician communication, an in-house specialty pharmacy with home delivery of certain medications, the ability to offer intravesical chemotherapy for treating urinary tract diseases and patient financial counseling.

TCU joins AON headshots

“The partnership with AON enables us to build upon the services we currently offer as well as improve the services and offer additional services that elevate patient care,” said Seth Hollenbach, MD, Board-certified urologist at Triple Crown Urology. “AON’s mission is aligned with our mission of delivering high-quality and compassionate patient care. Our partnership will benefit our patients, and we are honored to be part of such an esteemed network of healthcare leaders.”

“We are excited to welcome Triple Crown Urology to our network,” said Todd Schonherz, AON’s chief executive officer. “Triple Crown Urology offers advanced and innovative urology treatments and delivers care that is high quality and patient centered. We look forward to their continued success in southwest Arkansas.”

“AON is excited to expand its reach beyond oncology with Triple Crown Urology, which gives AON the opportunity to offer to another medical specialty our key patient care services such as the in-house specialty pharmacy with home delivery of prescriptions and financial counseling,” said Anthony Belott, AON’s chief development officer. “These services are essential to patient care and not exclusive to oncology, and our partnership with Triple Crown Urology demonstrates that we have resources that can help practices even outside the oncology specialty thrive.”

For more information about AON, visit www.aoncology.com/. For more information about Triple Crown Urology, visit www.TripleCrownUrology.com.

###

About American Oncology Network
The American Oncology Network (AON), an Inc. 5000-recognized company, is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents 107 physicians and 86 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at www.aoncology.com/.

About Triple Crown Urology
Triple Crown Urology is dedicated to being the foremost urology practice in Southwest Arkansas providing comprehensive treatment and services to men and women of all ages. We treat diseases and complications of the male and female urinary tract including urinary tract infections (UTI’s), urinary incontinence, overactive bladder, interstitial cystitis, prostatitis, enlarged prostate, kidney stones, and male and female infertility. We also treat problems with male reproductive organs, including penile implants for patients suffering with erectile dysfunction. Through compassionate care that centers around the patient, we strive to provide the best possible experience throughout the healthcare journey. Learn more at www.TripleCrownUrology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com